Materias dentro de su búsqueda.
Mostrando 2,281 - 2,300 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.34s Limitar resultados
  1. 2281
    “…The helicase portion of the hepatitis C virus nonstructural protein 3 (NS3) is considered one of the most validated targets for developing direct acting antiviral agents. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PBDE: Structure-Activity Studies for the Inhibition of Hepatitis C Virus NS3 Helicase
  2. 2282
    “…The experimental results indicate that of the twenty newly synthesized imidazole–coumarin conjugates, three of them exhibited appealing EC(50) values (5.1–8.4 μM) and selective indices >20 against hepatitis C virus. Their potency and selectivity were increased substantially by modification of their structure with two factors: imidazole nucleus with a hydrogen atom at the N(1) position and coumarin nucleus with a substituent, such as Cl, F, Br, Me, and OMe. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Synthesis and Structure-Activity Relationships of Imidazole-Coumarin Conjugates against Hepatitis C Virus
  3. 2283
    “…BACKGROUND: Hepatitis C virus (HCV) infection is a global epidemic with an estimated 71 million people infected worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective
  4. 2284
    “…PURPOSE: People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
  5. 2285
    “…OBJECTIVES: People with a history of injecting drugs have high prevalence of hepatitis C virus (HCV) infection, and many have opioid use disorder (OUD). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder
  6. 2286
    “…Hepatitis C virus (HCV) infection has been shown to affect kidneys with various histopathological pattern on the kidney biopsy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Virus-associated Membranoproliferative Glomerulonephritis Treated with Directly Acting Antiviral Therapy
  7. 2287
    “…Clinical risk prediction models in chronic hepatitis C virus (CHC) can be challenging due to non-linear nature of disease progression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Machine learning models to predict disease progression among veterans with hepatitis C virus
  8. 2288
    “…IMPORTANCE: Infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality in the United States, and incidence has increased rapidly in recent years, likely owing to increased injection drug use. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
  9. 2289
    “…Background: Hepatitis C virus (HCV) contains a (+) ssRNA genome with highly conserved structural, functional RNA domains, many of them with unknown roles for the consecution of the viral cycle. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region
  10. 2290
    “…Hepatitis C virus infection is associated with increased morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Possible acute rejection associated with the use of the new anti-hepatitis C virus medications
  11. 2291
    “…Hepatitis C virus (HCV) is responsible for a vast majority of liver failure cases. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of Preventive Vaccines for Hepatitis C Virus E1/E2 Protein
  12. 2292
    “…BACKGROUND: Infection with Hepatitis C Virus (HCV) increases the hepatotoxicity of anti-tuberculosis drugs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of Hepatitis C Virus in Tuberculosis Patients: A Systematic Review and Meta-Analysis
  13. 2293
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
  14. 2294
    “…Aim of this study was to outline the changes in the epidemiology of Hepatitis C genotypes in Southern Italy regions from 2006 to 2014. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy
  15. 2295
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals
  16. 2296
    “…We applied the Health Equity Implementation Framework to a historical healthcare disparity challenge—hepatitis C virus (HCV) and its treatment among Black patients seeking care in the US Department of Veterans Affairs (VA). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment
  17. 2297
    “…The treatment of patients with chronic hepatitis C virus (HCV) infection has changed tremendously over the past 2 years, with an increasing variety of all-oral direct-acting antiviral (DAA) treatment regimens available for different HCV genotypes and distinct clinical settings. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
  18. 2298
    “…Background and Aims: Polymorphisms in the immune response genes can contribute to clearance of hepatitis C virus (HCV) infection but also mediate liver inflammation and cancer pathogenesis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
  19. 2299
    “…Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
  20. 2300
    “…BACKGROUND: Hepatitis C virus (HCV) is currently classified into 8 genotypes and 86 subtypes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification
Herramientas de búsqueda: RSS